Loading organizations...
§ Private Profile · Brisbane, CA, USA
Develops connected automated external defibrillators (AEDs) and emergency response software to improve sudden cardiac arrest survival.
Based in Brisbane, California, Avive Solutions develops connected automated external defibrillators and emergency response software designed to improve survival rates for sudden cardiac arrest incidents. The company generates revenue through the sale of its FDA-approved hardware devices alongside recurring subscription fees for its fleet management and emergency network software. Their integrated platform alerts nearby responders and shares critical incident data directly with dispatchers, serving a diverse customer base that includes emergency medical services, corporate workplaces, community organizations, and educational institutions. To scale its commercial growth and operations, the enterprise has secured over $85 million in total funding, including a $56.5 million Series B round backed by lead investors Questa Capital, RC Capital, Catalyst Health Ventures, and Laerdal Million Lives Fund. Avive Solutions was founded in 2017 by Sameer Jafri, Rory Beyer, and Moseley Andrews.
Avive Solutions has raised $150.9M across 6 funding rounds.
Avive Solutions has raised $150.9M in total across 6 funding rounds.
Avive Solutions has raised $150.9M across 6 funding rounds. Most recently, it raised $56.5M Other Equity in April 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 19, 2024 | $56.5M Venture Round | Catalyst Health Ventures, Laerdal, Ryan Drant | Eckuity Capital | Announced |
| Feb 1, 2024 | $57M Series B | — | Autism Impact Fund, Deerfield Management, Questa Capital | Announced |
| Mar 1, 2022 | $22M Series A | Questa Capital, Darshana Zaveri, Laerdal | Autism Impact Fund, Deerfield Management | Announced |
| Jun 25, 2020 | $7M Venture Round | Jeff Trost | IrishAngels, Kenko Venture Partners | Announced |
| Jun 1, 2019 | $5M Series A | — | Vitalize Venture Group | Announced |
| Dec 3, 2018 | $3.4M Seed | Jeff Trost | HealthTech Capital, Hippocrates VC, Rock Health | Announced |
Avive Solutions is a Brisbane, California-based healthcare technology company founded in 2017 that develops the Avive Connect AED®, the smallest, lightest, and first new FDA-approved automated external defibrillator (AED) to enter the U.S. market in nearly 20 years.[1][2][3][5] It serves communities, schools, police departments, cities, and organizations by addressing out-of-hospital cardiac arrest (OHCA)—a leading cause of death with low survival rates—through connected hardware and the REALConnect™ software platform that integrates with 911 systems, provides real-time AED fleet insights, and automates maintenance to boost response times and survivability.[1][2][3][4] The company demonstrates strong growth momentum, including a 2024 NASPO ValuePoint® contract for AEDs (2024-2029), ranking #3 in Fast Company's 2025 Most Innovative Companies (Small and Mighty category), and real-world deployments like saving lives in Forsyth County, GA, Northern KY, and Cumberland County via its 4 Minute Community™ program.[1][2][3][4]
Avive Solutions was co-founded in 2017 by CEO Sameer Jafri, Rory, and Moseley, blending Jafri's experience in sudden cardiac arrest (SCA) prevention from his non-profit Saving Hearts Foundation with Rory and Moseley's technical expertise and novel AED concept developed at MIT.[5] The idea emerged from recognizing the "massive global problem" of SCA, where traditional standalone AEDs fail to integrate into broader response systems, leaving most OHCA cases untreated despite bystander potential.[1][4][5] Early traction built through innovation in connected AEDs, culminating in FDA approval after nearly 20 years without new entrants, and pivotal 2024 launches like QuickRescue™ (direct 911 alerting via RapidSOS partnership) and Intelligent Response™ for dispatcher-led bystander activation.[2][3]
Avive rides the trend of connected health tech and IoT integration in emergency response, transforming passive AEDs into active ecosystem nodes amid rising demand for rapid OHCA intervention—where survival drops 10% per minute without defibrillation.[1][4][5] Timing aligns with post-pandemic focus on public health infrastructure, FDA openness to innovation after two decades, and partnerships like RapidSOS accelerating 911 upgrades.[2][3] Market forces favoring Avive include massive SCA scale (leading U.S. killer outside hospitals), underutilized bystander AEDs, and government contracts like NASPO enabling scalable deployment to schools, cities, and fleets.[1][4] It influences the ecosystem by setting standards for 911-AED connectivity, inspiring "connected communities," and proving tech can humanize life-saving actions, potentially raising national survival rates from ~10%.[2][3][5]
Avive is poised for expansion through national contracts, further 911 integrations, and global SCA markets, leveraging its first-mover connectivity edge to dominate smart AEDs.[1][2][3] Trends like AI-driven response analytics, broader RapidSOS adoption, and public mandates for AEDs in high-risk venues will propel growth, while data from deployments refines REALConnect™ for predictive maintenance.[3][4] Its influence may evolve from innovator to ecosystem leader, partnering with more cities and providers to make "no witnessed SCA untreated" a reality—building on its mission to empower everyday rescuers with tech that turns emergencies into successes.[5]
Avive Solutions has raised $150.9M in total across 6 funding rounds.
Avive Solutions's investors include Catalyst Health Ventures, Laerdal, Ryan Drant, Eckuity Capital, Autism Impact Fund, Deerfield Management, Questa Capital, Darshana Zaveri, Jeff Trost, IrishAngels, Kenko Venture Partners, Vitalize Venture Group.